Abstract
Cancer is a unique disease which requires special attention to the affected patients and families right from the time of diagnosis. These patients develop peculiar physical, psychological, social, and spiritual needs that require a multidimensional approach to address them. It is therefore important for clinicians to have background knowledge of such special needs when caring for these patients. The presentation of palliative care cases can be disease specific, just like in many other medical cases. The disease trajectory, symptom profile, and the needs of cancer patients may be different from those of non-cancer cases. Even among cancer cases, there may be differences based on specific disease types and patient demographics such as age, gender, and ethnicity. It is also known that although there may be some differences in the physical symptoms, the psychological, social, and spiritual needs of these patients are invariably similar. The ultimate goal of palliative care is to deliver care that is patient specific rather than disease specific, and therefore personalized care is key to the delivery of a successful palliative intervention. The concept of prognostication is very important to both clinicians and patients and family members, but, regrettably, it is not well understood even among clinicians.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abernethy A, Shelby-James T, Fazekas B, Woods D, Currow D (2005) The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481]. BMC Palliat Care 4(1):7
Addington-Hall JM, MacDonald LD, Anderson HR (1990) Can the Spitzer Quality of Life Index help to reduce prognostic uncertainty in terminal care? Br J Cancer 62(4):695–699
Ahmed N, Bestall JC, Ahmedzai SH, Payne SA, Clark D, Noble B (2004) Systematic review of the problems and issues of accessing specialist palliative care by patients, carers and health and social care professionals. Palliat Med 18(6):525–542
American Cancer Society (2013) Cancer Facts & Figures 2013. American Cancer Society, Atlanta
Anderson F, Downing GM, Hill J, Casorso L, Lerch N (1996) Palliative performance scale (PPS): a new tool. J Palliat Care 12(1):5–11
Auret K, Bulsara C, Joske D (2003) Australasian haematologist referral patterns to palliative care: lack of consensus on when and why. Intern Med J 33(12):566–571, doi:490 [pii]
Bernabei R, Gambassi G, Lapane K, Landi F, Gatsonis C, Dunlop R, Lipsitz L, Steel K, Mor V (1998) Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology. JAMA 279(23):1877–1882, doi:joc71977 [pii]
Bruera E, Miller MJ, Kuehn N, MacEachern T, Hanson J (1992) Estimate of survival of patients admitted to a palliative care unit: a prospective study. J Pain Symptom Manage 7(2):82–86
Cheson BD (2002) Hematologic malignancies: new developments and future treatments. Semin Oncol 29(4 Suppl 13):33–45
Christakis NA, Iwashyna TJ (1998) Attitude and self-reported practice regarding prognostication in a national sample of internists. Arch Intern Med 158(21):2389–2395. doi:10.1001/archinte.158.21.2389
Delgado-Guay MO, Parsons HA, Li Z, Palmer LJ, Bruera E (2009) Symptom distress, interventions, and outcomes of intensive care unit cancer patients referred to a palliative care consult team. Cancer 115(2):437–445. doi:10.1002/cncr.24017
Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO Jr, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69(4):491–497
Escalante CP, Martin CG, Elting LS, Price KJ, Manzullo EF, Weiser MA, Harle TS, Cantor SB, Rubenstein EB (2000) Identifying risk factors for imminent death in cancer patients with acute dyspnea. J Pain Symptom Manage 20(5):318–325
Evans C, McCarthy M (1985) Prognostic uncertainty in terminal care: can the Karnofsky index help? Lancet 325(8439):1204–1206. doi:http://dx.doi.org/10.1016/S0140-6736(85)92876-4
Fadul N, Elsayem A, Palmer JL, Zhang T, Braiteh F, Bruera E (2007) Predictors of access to palliative care services among patients who died at a Comprehensive Cancer Center. J Palliat Med 10(5):1146–1152. doi:10.1089/jpm.2006.0259
Fadul NA, El Osta B, Dalal S, Poulter VA, Bruera E (2008) Comparison of symptom burden among patients referred to palliative care with hematologic malignancies versus those with solid tumors. J Palliat Med 11(3):422–427. doi:10.1089/jpm.2007.0184
Fries JF, Ehrlich GE (1981) Prognosis: contemporary outcomes of disease. The Charles Press Publishers, Bowie
Ganz PA, Lee JJ, Siau J (1991) Quality of life assessment. An independent prognostic variable for survival in lung cancer. Cancer 67(12):3131–3135
Glare P, Virik K, Jones M, Hudson M, Eychmuller S, Simes J, Christakis N (2003) A systematic review of physicians’ survival predictions in terminally ill cancer patients. BMJ 327 (7408):195–198. doi:10.1136/bmj.327.7408.195, 327/7408/195 [pii]
Glare P, Sinclair C, Downing M, Stone P, Maltoni M, Vigano A (2008) Predicting survival in patients with advanced disease. Eur J Cancer 44(8):1146–1156. doi:http://dx.doi.org/10.1016/j.ejca.2008.02.030
Goldstein NE, Lynn J (2006) Trajectory of end-stage heart failure: the influence of technology and implications for policy change. Perspect Biol Med 49(1):10–18
Hampton T (2007) New blood cancer therapies under study. JAMA 297(5):457–458. doi:10.1001/jama.297.5.457, 297/5/457 [pii]
Hui D, Elsayem A, Li Z, De La Cruz M, Palmer JL, Bruera E (2010) Antineoplastic therapy use in patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center: a simultaneous care model. Cancer 116(8):2036–2043. doi:10.1002/cncr.24942
Hui D, Kim SH, Kwon JH, Tanco KC, Zhang T, Kang JH, Rhondali W, Chisholm G, Bruera E (2012) Access to palliative care among patients treated at a comprehensive cancer center. Oncologist 17(12):1574–1580. doi:10.1634/theoncologist.2012-0192, theoncologist.2012-0192 [pii]
Langendijk H, Aaronson NK, de Jong JM, ten Velde GP, Muller MJ, Wouters M (2000) The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol 55(1):19–25
Llobera J, Esteva M, Rifa J, Benito E, Terrasa J, Rojas C, Pons O, Catalan G, Avella A (2000) Terminal cancer. Duration and prediction of survival time. Eur J Cancer 36(16):2036–2043
Loprinzi CL, Laurie JA, Wieand HS, Krook JE, Novotny PJ, Kugler JW, Bartel J, Law M, Bateman M, Klatt NE (1994) Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group. J Clin Oncol 12(3):601–607
Lunney JR, Lynn J, Hogan C (2002) Profiles of older medicare decedents. J Am Geriatr Soc 50(6):1108–1112. doi:10.1046/j.1532-5415.2002.50268.x
Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM (2003) Patterns of functional decline at the end of life. JAMA 289(18):2387–2392. doi:10.1001/jama.289.18.2387289/18/2387 [pii]
Lynn J, Adamson D (2003) Rand Corporation., Living well at the end of life: adapting health care to serious chronic illness in old age; white paper; Santa Monica CA; RAND; WP-137:iii, 19p. http://www.semeg.es/docs/docum/Rand_Health_White_Paper.pdf
Maltoni M, Pirovano M, Scarpi E, Marinari M, Indelli M, Arnoldi E, Gallucci M, Frontini L, Piva L, Amadori D (1995) Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric study. Cancer 75(10):2613–2622
Maltoni M, Pirovano M, Nanni O, Marinari M, Indelli M, Gramazio A, Terzoli E, Luzzani M, De Marinis F, Caraceni A, Labianca R (1997) Biological indices predictive of survival in 519 Italian terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care. J Pain Symptom Manage 13(1):1–9
Maltoni M, Nanni O, Pirovano M, Scarpi E, Indelli M, Martini C, Monti M, Arnoldi E, Piva L, Ravaioli A, Cruciani G, Labianca R, Amadori D (1999) Successful validation of the palliative prognostic score in terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care. J Pain Symptom Manage 17(4):240–247
Mander T (1997) Haematology and palliative care: an account of shared care for a patient undergoing bone marrow transplantation for chronic myeloid leukaemia. Int J Nurs Pract 3(1):62–66
McGrath P (2001) Dying in the curative system: the haematology/oncology dilemma. Part 1. Aust J Holist Nurs 8(2):22–30
McGrath P, Holewa H (2007) Special considerations for haematology patients in relation to end-of-life care: Australian findings. Eur J Cancer Care (Engl) 16(2):164–171. doi:10.1111/j.1365-2354.2006.00745.x
Mor V, Laliberte L, Morris JN, Wiemann M (1984) The Karnofsky performance status scale: an examination of its reliability and validity in a research setting. Cancer 53(9):2002–2007. doi:10.1002/1097-0142(19840501)53:9<2002:AID-CNCR2820530933>3.0.CO;2-W
Morita T, Tsunoda J, Inoue S, Chihara S (1999) Survival prediction of terminally ill cancer patients by clinical symptoms: development of a simple indicator. Jpn J Clin Oncol 29(3):156–159
Morris JN, Suissa S, Sherwood S, Wright SM, Greer D (1986) Last days: a study of the quality of life of terminally ill cancer patients. J Chronic Dis 39(1):47–62. doi:http://dx.doi.org/10.1016/0021-9681(86)90106-2
Nikoletti S, Porock D, Kristjanson LJ, Medigovich K, Pedler P, Smith M (2000) Performance status assessment in home hospice patients using a modified form of the Karnofsky Performance Status Scale. J Palliat Med 3(3):301–311. doi:10.1089/jpm.2000.3.301
Pirovano M, Maltoni M, Nanni O, Marinari M, Indelli M, Zaninetta G, Petrella V, Barni S, Zecca E, Scarpi E, Labianca R, Amadori D, Luporini G (1999) A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative Care. J Pain Symptom Manage 17(4):231–239
Portenoy RK, Sibirceva U, Smout R, Horn S, Connor S, Blum RH, Spence C, Fine PG (2006) Opioid use and survival at the end of life: a survey of a hospice population. J Pain Symptom Manage 32(6):532–540. doi:10.1016/j.jpainsymman.2006.08.003
Rosenthal MA, Gebski VJ, Kefford RF, Stuart-Harris RC (1993) Prediction of life-expectancy in hospice patients: identification of novel prognostic factors. Palliat Med 7(3):199–204
Sinclair C (2007) Prognosis Links. Pallimed: a Hospice & Palliative Medicine blog. http://prognosis.pallimed.org/. Accessed 31 Mar 2014
Steyerberg EW, Harrell FE Jr (2002) Statistical models for prognostication. Symptom research: methods and opportunities. National Institute of Health, Bethesda
Tranmer JE, Heyland D, Dudgeon D, Groll D, Squires-Graham M, Coulson K (2003) Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the memorial symptom assessment scale. J Pain Symptom Manage 25(5):420–429
Vigano A, Bruera E, Suarez-Almazor ME (1999) Terminal cancer syndrome: myth or reality? J Palliat Care 15(4):32–39
Viganò A, Dorgan M, Buckingham J, Bruera E, Suarez-Almazor ME (2000) Survival prediction in terminal cancer patients: a systematic review of the medical literature. Palliat Med 14(5):363–374
Wachtel T, Allen-Masterson S, Reuben D, Goldberg R, Mor V (1988) The end stage cancer patient: terminal common pathway. Hosp J 4(4):43–80
Walsh JS, Welch HG, Larson EB (1990) Survival of outpatients with Alzheimer-type dementia. Ann Intern Med 113(6):429–434. doi:10.7326/0003-4819-113-6-429
Walsh D, Donnelly S, Rybicki L (2000) The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 8(3):175–179
Wolfson C, Wolfson DB, Asgharian M, M’Lan CE, Østbye T, Rockwood K, Hogan DB (2001) A reevaluation of the duration of survival after the onset of dementia. N Engl J Med 344(15):1111–1116. doi:10.1056/NEJM200104123441501
Xie J, Brayne C, Matthews FE (2008) Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up. BMJ 336(7638):258–262. doi:10.1136/bmj.39433.616678.25 10.1136/bmj.39433.616678.25
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Arthur, J.A., Bruera, E. (2015). Disease-Specific Oncology – Disease-Specific Palliative Care. In: Alt-Epping, B., Nauck, F. (eds) Palliative Care in Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46202-7_1
Download citation
DOI: https://doi.org/10.1007/978-3-662-46202-7_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-46201-0
Online ISBN: 978-3-662-46202-7
eBook Packages: MedicineMedicine (R0)